Caxton Corporation’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,040
| Closed | -$162K | – | 11 |
|
|
2017
Q1 | $162K | Buy |
1,040
+22
| +2% | +$3.43K | 0.46% | 10 |
|
|
2016
Q4 | $212K | Buy |
1,018
+97
| +11% | +$20.2K | 0.72% | 11 |
|
|
2016
Q3 | $211K | Sell |
921
-19
| -2% | -$4.35K | 0.94% | 8 |
|
|
2016
Q2 | $194K | Buy |
940
+299
| +47% | +$61.7K | 0.22% | 10 |
|
|
2016
Q1 | $163K | Hold |
641
| – | – | 0.22% | 13 |
|
|
2015
Q4 | $220K | Buy |
+641
| New | +$220K | 0.92% | 10 |
|